PVT

Pivotal Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of therapeutic products for the treatment of cardiovascular disease and related conditions. The company's lead product, VASCAZEN, is a prescription-only medical food formulated to meet the specific dietary needs of patients with cardiovascular disease who are deficient in blood Omega-3 fatty acids. Pivotal also developed OMAZEN, a pharmaceutical-grade Omega-3 for general health maintenance, and was advancing PVT-100 for the stabilization of vulnerable plaque in patients undergoing carotid endarterectomy. Headquartered in Woodbridge, Canada, the company utilized its expertise in lipid science to address unmet medical needs in the cardiometabolic space.